SCHEMBL16410795

SCHEMBL16410795

[N-]=[N+]=NCN(CN=[N+]=[N-])c1ccccc1CNNC1=Nc2ccccc2NC12CCOCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16410635 0.90 ACAT2 (0.34) —
SCHEMBL16410796 0.82 ACAT2 (0.30) —
SCHEMBL16410627 0.77 SLC6A2 (0.33) —
SCHEMBL16410827 0.76 — —
SCHEMBL16410800 0.75 BRD4 (0.35) —
SCHEMBL17992067 0.74 APP (0.32) —
SCHEMBL16410745 0.72 TAAR1 (0.35) —
SCHEMBL16410735 0.71 — —
SCHEMBL16410791 0.71 ACAT2 (0.33) —
SCHEMBL16410616 0.71 ACAT2 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015007730-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2015-01-22 — — WO disclosed
Send feedback